The National Institutes of Health “Methods and Measurement in Sexual & Gender Minority Health Research: Identifying Research Opportunities”, 9538-9539 [2019-04790]
Download as PDF
9538
Federal Register / Vol. 84, No. 51 / Friday, March 15, 2019 / Notices
Patricia M. Busche,
Project Clearance Liaison, National Cancer
Institute, National Institutes of Health.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2019–04856 Filed 3–14–19; 8:45 am]
National Institutes of Health
BILLING CODE 4140–01–P
Center for Scientific Review; Notice of
Closed Meetings
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
amozie on DSK9F9SC42PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel; RFA–AA–19–001 Limited
Competition: Collaborative Study on the
Genetics of Alcoholism (COGA).
Date: April 29, 2019.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Main
Conference Hall, 6700A Rockledge Drive,
Bethesda, MD 20817.
Contact Person: Beata Buzas, Ph.D.,
Scientific Review Officer, National Institute
on Alcohol Abuse and Alcoholism, National
Institutes of Health, 6700B Rockledge Drive,
Room 2116, Bethesda, MD 20852, 301–443–
0800, bbuzas@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards, National
Institutes of Health, HHS)
Dated: March 11, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–04852 Filed 3–14–19; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
16:53 Mar 14, 2019
Jkt 247001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Autism and Other
Neurodevelopmental Disorders.
Date: March 26, 2019.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Samuel C. Edwards, Ph.D.,
Chief, BDCN IRG, Center for Scientific
Review, National Institutes of Health, 6701
Rockledge Drive, Room 5210, MSC 7846,
Bethesda, MD 20892, (301) 435–1246,
edwardss@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Toxicology
and Digestive, Kidney and Urological
Systems AREA Review.
Date: April 3, 2019.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Ganesan Ramesh, Ph.D.,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 2182 MSC 7818, Bethesda, MD 20892,
301–827–5467, ganesan.ramesh@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
Dated: March 12, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–04850 Filed 3–14–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
The National Institutes of Health
‘‘Methods and Measurement in Sexual
& Gender Minority Health Research:
Identifying Research Opportunities’’
ACTION:
Request for comments.
Sexual and gender minority
(SGM) is an umbrella phrase that
encompasses lesbian, gay, bisexual, and
transgender populations as well as those
whose sexual orientation, gender
identity and expressions, or
reproductive development varies from
traditional, societal, cultural, or
physiological norms. This includes
Disorders or Differences in Sex
Development (DSD), sometimes known
as intersex.
The Sexual & Gender Minority
Research Office (SGMRO) at the
National Institutes of Health (NIH) has
developed the document ‘‘Methods and
Measurement in Sexual & Gender
Minority Health Research: Identifying
Research Opportunities’’ pertaining
specifically and exclusively to methods
and measurement research in SGM
health research. Experts in the field
identified research opportunities related
to methods and measurement in SGM
health research during a workshop held
in the Spring of 2018. The document
reflects the content of the discussion
among participants at the Methods and
Measurement in SGM Health Research
Workshop and does not represent an
official position of NIH or any other
government agency. We would like to
obtain comment on the specifics of this
document to consider for the purposes
of informing and enhancing its content.
DATES: To ensure consideration of your
comments, responses must be received
by April 15, 2019.
ADDRESSES: Responses to this notice
must be submitted electronically by
email to sgmhealthresearch@od.nih.gov.
Please use the subject ‘‘Comments:
Measurement.’’
SUMMARY:
Dr.
Karen Parker, Division of Program
Coordination, Planning, and Strategic
Initiatives, Office of the Director, NIH,
Building 1, Room 257, 1 Center Drive,
FOR FURTHER INFORMATION CONTACT:
E:\FR\FM\15MRN1.SGM
15MRN1
Federal Register / Vol. 84, No. 51 / Friday, March 15, 2019 / Notices
Bethesda, MD 20892, Telephone: 301–
451–2055, Email: karen.parker@nih.gov.
SUPPLEMENTARY INFORMATION:
amozie on DSK9F9SC42PROD with NOTICES
Background
In 2015, the National Institutes of
Health (NIH) established the Sexual &
Gender Minority Research Office
(SGMRO) in the Division of Program
Coordination, Planning, and Strategic
Initiatives in the Office of the Director.
The role of the SGMRO is to: Coordinate
sexual and gender minority (SGM)
health research activities across NIH;
represent NIH at conferences and events
on trans-NIH activities focused on SGM
research; coordinate and convene
conferences and workshops to inform
priority setting and research activities;
collaborate with NIH Institutes and
Centers on the development of SGM
health research reports; manage
information dissemination related to
SGM research; and work with NIH
Institutes and Centers to leverage
resources and develop initiatives to
support SGM health research.
The 21st Century Cures Act, signed
into law on December 13, 2016,
included SGM-specific provisions, by
amending the Public Health Service Act,
SEC. 404N. [283] POPULATION
FOCUSED RESEARCH. Those
provisions are summarized as follows:
‘‘The Director of the National
Institutes of Health shall, as appropriate,
encourage efforts to improve research
related to the health of sexual and
gender minority populations, including
by: facilitating increased participation of
sexual and gender minority populations
in clinical research supported by the
National Institutes of Health, and
reporting on such participation, as
applicable; facilitating the development
of valid and reliable methods for
research relevant to sexual and gender
minority populations; and addressing
methodological challenges.’’
As a result of the growing need to
develop better measures and methods to
accurately capture and understand the
health of SGM populations, the SGMRO
hosted a workshop to identify research
opportunities in methods and
measurement in SGM-related health
research. The planning committee
included both NIH staff and extramural
researchers who designed the workshop
agenda and developed a schema to
guide the discussions.
The workshop focused on three areas:
Measurement of SGM status;
measurement of related constructs; and
sampling. Extramural researchers were
invited who represented various
research areas, stages of career,
populations of interest, and disciplines.
VerDate Sep<11>2014
16:53 Mar 14, 2019
Jkt 247001
Community members, NIH staff, and
other federal staff were also included.
Discussions focused around varying
concepts to consider under each of the
domains identified by the planning
committee; overarching themes of
intersectionality, lifespan, culture, and
historical context and cohort effects
were considered throughout the
discussions. The concepts for
consideration are highlighted below:
I. Measurement of SGM Status
Æ Sexual Orientation (identity,
behavior, attraction)
Æ Gender Identity (cisgender,
transgender, gender nonconforming,
non-binary)
Æ Disorders or Differences of Sex
Development/Intersex (medical
condition at birth vs. self-identified)
Æ Fluidity (identity across contexts,
time, and developmental stage)
Æ Assessment Modality (survey, report,
collection from a provider, on the
phone, internet, paper)
Æ Clinical Settings
II. Measurement of Related Constructs
Æ Stigma (structural, interpersonal,
individual or internalized)
Æ Coming Out/Disclosure Process
Æ Family Relationships
Æ Cultural Competence/Humility in the
Healthcare and Research Settings
(providers, facilities, etc.)
III. Sampling
Æ Probability vs. Non-Probability
Sampling
Æ Sampling Across Demographics/Subpopulations
Æ Small Sample Sizes
Information Requested
This notice invites public comment
on the proposed research needs and
opportunities developed at the Methods
and Measurement in Sexual and Gender
Minority Health Research Workshop. To
inform the final document, comment is
requested on the following questions:
(1) What are the most important and
relevant methods and measurementrelated research questions to members
of the SGM community?
(2) What are the key methods and
measurement-related research questions
missing from the research opportunities
that should be included?
Comments regarding this information
collection are best assured of having
their full effect if received within 30
days of the date of this publication.
April 15, 2019.
General Information
All of the following fields in the
response are optional and voluntary.
PO 00000
Frm 00064
Fmt 4703
Sfmt 9990
9539
Any personal identifiers will be
removed when responses are compiled.
Proprietary, classified, confidential, or
sensitive information should not be
included in your response. This notice
is for planning purposes only and is not
a solicitation for applications or an
obligation on the part of the United
States (U.S.) government to provide
support for any ideas identified in
response to it. Please note that the U.S.
government will not pay for the
preparation of any comment submitted
or for its use of that comment.
Please indicate if you are one of the
following: Grantee or other PI,
administrator, student, institutional
leader or institutional administrator,
NIH employee, or other. If you are an
investigator, please indicate your career
level and main area of research interest,
including whether the focus is clinical
or basic. If you are a member of a
particular advocacy or professional
organization, please indicate the name
and primary focus of the organization
(e.g., research support, patient care, etc.)
and whether you are responding on
behalf of your organization (if yes,
please indicate your position within the
organization). Please provide your name
and email address.
Privacy Act Notification Statement:
We are requesting your comments for
Methods and Measurement in Sexual &
Gender Minority Health Research:
Developing a Research Agenda and
Identifying Research Opportunities
(https://dpcpsi.nih.gov/sites/default/
files/MethodsMeasures_Paper_508_
FV.pdf). The information you provide
may be disclosed to NIH senior staff and
those serving on the SGM Research
Coordinating Committee and to
contractors working on our behalf.
Submission of this information is
voluntary. However, the information
you provide will help to categorize
responses by scientific area of expertise,
organizational entity or professional
affiliation.
Collection of this information is
authorized under 42 U.S.C. 203, 24 1,
2891–1 and 44 U.S.C. 310 I and Section
30l and 493 of the Public Health Service
Act regarding the establishment of the
National Institutes of Health, its general
authority to conduct and fund research
and to provide training assistance, and
its general authority to maintain records
in connection with these and its other
functions.
Dated: March 8, 2019.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2019–04790 Filed 3–14–19; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\15MRN1.SGM
15MRN1
Agencies
[Federal Register Volume 84, Number 51 (Friday, March 15, 2019)]
[Notices]
[Pages 9538-9539]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-04790]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
The National Institutes of Health ``Methods and Measurement in
Sexual & Gender Minority Health Research: Identifying Research
Opportunities''
ACTION: Request for comments.
-----------------------------------------------------------------------
SUMMARY: Sexual and gender minority (SGM) is an umbrella phrase that
encompasses lesbian, gay, bisexual, and transgender populations as well
as those whose sexual orientation, gender identity and expressions, or
reproductive development varies from traditional, societal, cultural,
or physiological norms. This includes Disorders or Differences in Sex
Development (DSD), sometimes known as intersex.
The Sexual & Gender Minority Research Office (SGMRO) at the
National Institutes of Health (NIH) has developed the document
``Methods and Measurement in Sexual & Gender Minority Health Research:
Identifying Research Opportunities'' pertaining specifically and
exclusively to methods and measurement research in SGM health research.
Experts in the field identified research opportunities related to
methods and measurement in SGM health research during a workshop held
in the Spring of 2018. The document reflects the content of the
discussion among participants at the Methods and Measurement in SGM
Health Research Workshop and does not represent an official position of
NIH or any other government agency. We would like to obtain comment on
the specifics of this document to consider for the purposes of
informing and enhancing its content.
DATES: To ensure consideration of your comments, responses must be
received by April 15, 2019.
ADDRESSES: Responses to this notice must be submitted electronically by
email to sgmhealthresearch@od.nih.gov. Please use the subject
``Comments: Measurement.''
FOR FURTHER INFORMATION CONTACT: Dr. Karen Parker, Division of Program
Coordination, Planning, and Strategic Initiatives, Office of the
Director, NIH, Building 1, Room 257, 1 Center Drive,
[[Page 9539]]
Bethesda, MD 20892, Telephone: 301-451-2055, Email:
karen.parker@nih.gov.
SUPPLEMENTARY INFORMATION:
Background
In 2015, the National Institutes of Health (NIH) established the
Sexual & Gender Minority Research Office (SGMRO) in the Division of
Program Coordination, Planning, and Strategic Initiatives in the Office
of the Director. The role of the SGMRO is to: Coordinate sexual and
gender minority (SGM) health research activities across NIH; represent
NIH at conferences and events on trans-NIH activities focused on SGM
research; coordinate and convene conferences and workshops to inform
priority setting and research activities; collaborate with NIH
Institutes and Centers on the development of SGM health research
reports; manage information dissemination related to SGM research; and
work with NIH Institutes and Centers to leverage resources and develop
initiatives to support SGM health research.
The 21st Century Cures Act, signed into law on December 13, 2016,
included SGM-specific provisions, by amending the Public Health Service
Act, SEC. 404N. [283] POPULATION FOCUSED RESEARCH. Those provisions are
summarized as follows:
``The Director of the National Institutes of Health shall, as
appropriate, encourage efforts to improve research related to the
health of sexual and gender minority populations, including by:
facilitating increased participation of sexual and gender minority
populations in clinical research supported by the National Institutes
of Health, and reporting on such participation, as applicable;
facilitating the development of valid and reliable methods for research
relevant to sexual and gender minority populations; and addressing
methodological challenges.''
As a result of the growing need to develop better measures and
methods to accurately capture and understand the health of SGM
populations, the SGMRO hosted a workshop to identify research
opportunities in methods and measurement in SGM-related health
research. The planning committee included both NIH staff and extramural
researchers who designed the workshop agenda and developed a schema to
guide the discussions.
The workshop focused on three areas: Measurement of SGM status;
measurement of related constructs; and sampling. Extramural researchers
were invited who represented various research areas, stages of career,
populations of interest, and disciplines.
Community members, NIH staff, and other federal staff were also
included. Discussions focused around varying concepts to consider under
each of the domains identified by the planning committee; overarching
themes of intersectionality, lifespan, culture, and historical context
and cohort effects were considered throughout the discussions. The
concepts for consideration are highlighted below:
I. Measurement of SGM Status
[cir] Sexual Orientation (identity, behavior, attraction)
[cir] Gender Identity (cisgender, transgender, gender nonconforming,
non-binary)
[cir] Disorders or Differences of Sex Development/Intersex (medical
condition at birth vs. self-identified)
[cir] Fluidity (identity across contexts, time, and developmental
stage)
[cir] Assessment Modality (survey, report, collection from a provider,
on the phone, internet, paper)
[cir] Clinical Settings
II. Measurement of Related Constructs
[cir] Stigma (structural, interpersonal, individual or internalized)
[cir] Coming Out/Disclosure Process
[cir] Family Relationships
[cir] Cultural Competence/Humility in the Healthcare and Research
Settings (providers, facilities, etc.)
III. Sampling
[cir] Probability vs. Non-Probability Sampling
[cir] Sampling Across Demographics/Sub-populations
[cir] Small Sample Sizes
Information Requested
This notice invites public comment on the proposed research needs
and opportunities developed at the Methods and Measurement in Sexual
and Gender Minority Health Research Workshop. To inform the final
document, comment is requested on the following questions:
(1) What are the most important and relevant methods and
measurement-related research questions to members of the SGM community?
(2) What are the key methods and measurement-related research
questions missing from the research opportunities that should be
included?
Comments regarding this information collection are best assured of
having their full effect if received within 30 days of the date of this
publication. April 15, 2019.
General Information
All of the following fields in the response are optional and
voluntary. Any personal identifiers will be removed when responses are
compiled. Proprietary, classified, confidential, or sensitive
information should not be included in your response. This notice is for
planning purposes only and is not a solicitation for applications or an
obligation on the part of the United States (U.S.) government to
provide support for any ideas identified in response to it. Please note
that the U.S. government will not pay for the preparation of any
comment submitted or for its use of that comment.
Please indicate if you are one of the following: Grantee or other
PI, administrator, student, institutional leader or institutional
administrator, NIH employee, or other. If you are an investigator,
please indicate your career level and main area of research interest,
including whether the focus is clinical or basic. If you are a member
of a particular advocacy or professional organization, please indicate
the name and primary focus of the organization (e.g., research support,
patient care, etc.) and whether you are responding on behalf of your
organization (if yes, please indicate your position within the
organization). Please provide your name and email address.
Privacy Act Notification Statement: We are requesting your comments
for Methods and Measurement in Sexual & Gender Minority Health
Research: Developing a Research Agenda and Identifying Research
Opportunities (https://dpcpsi.nih.gov/sites/default/files/MethodsMeasures_Paper_508_FV.pdf). The information you provide may be
disclosed to NIH senior staff and those serving on the SGM Research
Coordinating Committee and to contractors working on our behalf.
Submission of this information is voluntary. However, the information
you provide will help to categorize responses by scientific area of
expertise, organizational entity or professional affiliation.
Collection of this information is authorized under 42 U.S.C. 203,
24 1, 2891-1 and 44 U.S.C. 310 I and Section 30l and 493 of the Public
Health Service Act regarding the establishment of the National
Institutes of Health, its general authority to conduct and fund
research and to provide training assistance, and its general authority
to maintain records in connection with these and its other functions.
Dated: March 8, 2019.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2019-04790 Filed 3-14-19; 8:45 am]
BILLING CODE 4140-01-P